A Brief Report on Some Physiological Parameters of Streptozocin-Diabetic Rat

REFERENCES

• Riley T. N., Fischer R. G. Review of New Drugs 1982. U.S. Pharm. 1983 March; 31–46
   Google Scholar
• Al-Turk W. A., Stohs S. J., Roche E. B. Altered Metabolism of 7-Ethoxycoumarin by Hepatic, Pulmonary, and Intestinal Microsomes from Streptozotocin-Diabetic Rats. Drug Met. Disp. 1980; 8: 44–45
   PubMed Web of Science ®Google Scholar
• Tesone M., Oliveira-Filho R. M., Biella de Souza Valle L., Calvo J. C., Barañao J. L.S., Foglia V. G., Charreau E. H. Androgen Receptors in the Diabetic Rat. Diabetologia 1980; 18: 385–390
   PubMed Web of Science ®Google Scholar
• Warren B. L., Pak R., Finlayson M., Gontovnick L., Sunahara G., Bellward G. D. Differential Effects of Diabetes on Microsomal Metabolism of Various Substrates: Comparison of Streptozocin and Spontaneously Diabetic Wistar Rats. Biochem. Pharmacol. 1983; 32(2)327–335
   PubMed Web of Science ®Google Scholar
• Sato H., Trasaki T., Okumura K., Tsuji A. Effect of Receptor Up-Regulation on Insulin Pharmacokinetics in Streptozotocin-Treated Diabetic Rats. Pharm. Res. 1991; 8(5)563–569
   PubMed Web of Science ®Google Scholar
• Xiang H., McNeill J. H. Protein Kinase C Activity Is Altered in Diabetic Rat Hearts. Biochem. Biophys. Res. Commun. 1992; 187(2)703–710
   PubMed Web of Science ®Google Scholar
• Thompson K. H., McNeill J. H. Effect of Vanadyl Sulfate Feeding on Susceptibility to Peroxidative Change in Diabetic Rats. Res. Commun. Chem. Pathol. Pharmacol. 1993; 80(2)187–200
   PubMedGoogle Scholar
• Al-Achi A., Greenwood R., Walker B. Streptozocin Effect on Rat's Body Weight: A Retrospective Study. Proc. Seventh Int. Symp. Recent Advances Drug Delivery Sys. 1995; 149–150
   Google Scholar
• Stohs S. J., Reinke L. A., Hassing J. M., Rosenberg H. Benzo[a]pyrene Metabolism by Hepatic and Extrahepatic Tissues in Streptozotocin-Diabetic Rats. Drug Metab. Disp. 1979; 7(1)49
   PubMed Web of Science ®Google Scholar
• Bhardwaj R., Moore P. K. Increased Vasodilator Response to Acetylcholine of Renal Blood Vessels from Diabetic Rats. J. Pharm. Pharmacol. 1988; 40: 739–742
   PubMed Web of Science ®Google Scholar
• Kawada J., Tanaka N., Nozaki Y. No Reduction of Blood Glucose in Diabetic Rats After Oral Administration of Insulin Liposomes Prepared Under Acidic Conditions. Endocrinol. Jpn. 1981; 28(2)235–238
   PubMedGoogle Scholar
• Tozzo E., Desbuquois B. Effect of STZ-Induced Diabetes and Fasting on Insulin Receptor mRNA Expression and Insulin Receptor Gene Transcription in Rat Liver. Diabetes 1992; 41: 1609–1616
   PubMed Web of Science ®Google Scholar
• Al-Achi A., Greenwood R. Erythrocytes as Oral Delivery Systems for Human Insulin. Drug Dev. Ind. Pharm. 1998; 24(1)67–72
   PubMed Web of Science ®Google Scholar
• Gonzalez E., Jawerbaum A., Sinner D., Pustovrh C., Peralta C., Gomez G., Catafau J. Rosello, Gelpi E., Gimeno M. Evolution of Streptozotocin-Pancreatic Damage in the Rat: Modulatory Effect of Endothelins on the Nitridergic and Prostanoid Pathway. Nitric Oxide 1999; 3(6)459–466
   PubMed Web of Science ®Google Scholar
• Dapergolas G., Gregoriadis G. Hypoglyæmic Effect of Liposomes-Entrapped Insulin Administered Intragastrically into Rats. Lancet 1976; October 16: 824–827
   Google Scholar
• Winocour P. D., Lopes-Virella M., Laimins M., Colwell J. A. Effect of Insulin Treatment in Streptozocin- Induced Diabetic Rats on In Vitro Platelet Function and Plasma von Willebrand Factor Activity and Factor VIII-Related Antigen. J. Lab. Clin. Med. 1985; 106: 319–325
   PubMedGoogle Scholar
• Banks W. A., Jaspan J. B., Kastin A. J. Effect of Diabetes Mellitus on the Permeability of the Blood-Brain Barrier to Insulin. Peptides 1997; 18(10)1577–1584
   PubMed Web of Science ®Google Scholar
• Morrison M. H., Barber H. E., Foschi P. G., Hawksworth G. M. The Kinetics of 4-Nitrophenol Conjugation by Perfused Livers and Hepatic Microsomes from Streptozocin- Induced Diabetic Rats. J. Pharm. Pharmacol. 1986; 38: 188–194
   PubMed Web of Science ®Google Scholar
• Ackerman D. M., Leibman K. C. Effect of Experimental Diabetes on Drug Metabolism in the Rat. Drug Met. Depos. 1977; 5(4)405–410
   PubMed Web of Science ®Google Scholar
• Abrass C. K. Evaluation of the Presence of Circulating Immune Complexes and Their Relationship to Glomerular IgG Deposits in Streptozotocin-Induced Diabetic Rats. Clin. Exp. Immunol. 1984; 57: 17–24
   PubMed Web of Science ®Google Scholar
• Yavuz D. G., Ersoz O., Kucukkaya B., Budak Y., Ahiskali R., Ekicioglu G., Emerk K., Akalin S. The Effect of Losartan and Captopril on Glomerular Basement Membrane Anionic Charge in a Diabetic Rat Model. J. Hypertens. 1999; 17(8)1217–1223
   PubMed Web of Science ®Google Scholar
• Hamet P., Sugimoto H., Umeda F., Franks D. J. Platelets and Vascular Smooth Muscle: Abnormalities of Phosphodiesterase, Aggregation, and Cell Growth in Experimental and Human Diabetes. Metabolism 1983; 32(7, Suppl. 1)124–130
   PubMed Web of Science ®Google Scholar
• Glanville N. T., Anderson G. H. Altered Methionine Metabolism in Streptozotocin-Diabetic Rats. Diabetologia 1984; 27: 468–471
   PubMed Web of Science ®Google Scholar
• Sennoune S., Gerbi A., Duran M. J., Grillasca J. P., Compe E., Pierre S., Planells R., Bourdeaux M., Vague P., Pieroni G., Maixent J. M. Effect of Streptozotocin- Induced Diabetes on Rat Liver Na+/K+-ATPase. Eur. J. Biochem. 2000; 267(7)2071–2078
   PubMedGoogle Scholar
• Douillet C., Chancerelle Y., Cruz C., Maroncles C., Kergonou J. F., Renaud S., Ciavatti M. High Dosage Vitamin E Effect on Oxidative Status and Serum Lipids Distribution in Streptozocin-Induced Diabetic Rats. Biochem. Med. Metab. Biol. 1993; 50(3)265–276
   PubMedGoogle Scholar
• Al Shabanah O. A., El Kashef H. A., Badary O. A., Al Bekairi A. M., Elmazar M. M. Effect of Streptozotocin- Induced Hyperglycaemia on Intravenous Pharmacokinetics and Acute Cardiotoxicity of Doxorubicin in Rats. Pharmacol. Res. 2000; 41(1)31–37
   PubMed Web of Science ®Google Scholar